NCT07800650

Brief Summary

Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder characterized by recurrent abdominal pain and irregular bowel habits. Dietary interventions, particularly low-FODMAP and gluten-free diets, have gained increasing interest in IBS management. However, comparative data on these two approaches remain limited across different populations, including the Turkish population. This study was designed to compare the effectiveness of a 4-week low-FODMAP diet versus a gluten-free diet on gastrointestinal symptoms in Turkish patients with IBS. A total of 70 patients diagnosed with IBS according to Rome IV criteria were enrolled in this prospective, controlled, parallel-group clinical trial. Patients were sequentially assigned to either the low-FODMAP group (n=35) or the gluten-free diet group (n=35). Both dietary interventions were implemented over 4 weeks under the guidance of an experienced dietitian, with weekly telephone follow-ups to monitor dietary compliance. Gastrointestinal symptoms were evaluated at baseline and at the end of the intervention using the Gastrointestinal Symptom Rating Scale (GSRS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 24, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2026

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 25, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 2, 2026

Completed
Last Updated

September 2, 2026

Status Verified

August 1, 2026

Enrollment Period

7 months

First QC Date

August 25, 2026

Last Update Submit

August 28, 2026

Conditions

Keywords

Irritable Bowel Syndromelow-FODMAP dietgluten-free diet

Outcome Measures

Primary Outcomes (1)

  • Change in Total GSRS Score

    Change in the total Gastrointestinal Symptom Rating Scale (GSRS) score from baseline to 4 weeks. The GSRS is a 15-item scale with total scores ranging from 15 to 105. Higher scores indicate more severe gastrointestinal symptoms.

    Baseline and 4 weeks

Secondary Outcomes (5)

  • Change in GSRS Diarrhea Subscale Score

    Baseline and 4 weeks

  • Change in GSRS Indigestion Subscale Score

    Baseline and 4 weeks

  • Change in GSRS Constipation Subscale Score

    Baseline and 4 weeks

  • Change in GSRS Abdominal Pain Subscale Score

    Baseline and 4 weeks

  • Change in GSRS Reflux Subscale Score

    Baseline and 4 weeks

Study Arms (2)

Low-FODMAP Diet Group

EXPERIMENTAL

Participants followed a low-FODMAP diet for 4 weeks under the guidance of an experienced dietitian.

Other: Low-FODMAP Diet

Gluten-Free Diet Group

EXPERIMENTAL

Participants followed a strict gluten-free diet for 4 weeks under the guidance of an experienced dietitian.

Other: Gluten-Free Diet

Interventions

Participants were instructed to exclude gluten-containing grains (wheat, barley, rye) and their derivatives (bread, pasta, pastries), and to consume naturally gluten-free foods (rice, corn, potatoes, meat, vegetables, fruits). The diet was applied for 4 weeks.

Gluten-Free Diet Group

Participants were instructed to limit foods high in FODMAPs (onions, garlic, pulses, certain fruits and vegetables, wheat products) and to consume low-FODMAP alternatives (rice, oats, potatoes, carrots, bananas). The diet was applied for 4 weeks.

Low-FODMAP Diet Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with Irritable Bowel Syndrome (IBS) according to the Rome IV diagnostic criteria
  • Aged between 18 and 65 years
  • Literate
  • Signed the informed consent form

You may not qualify if:

  • Psychiatric or neurological condition affecting cooperation (dementia, psychosis, etc.)
  • Chronic condition (celiac disease, inflammatory bowel disease, diabetes, chronic kidney failure, liver failure, malignancy)
  • Regular use of medication for IBS symptoms (antispasmodics, loperamide, laxatives, antidepressants, etc.)
  • Eating disorder (anorexia nervosa, bulimia nervosa, etc.)
  • Malabsorption syndrome preventing adherence to the diet
  • Pregnancy or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yıldızkent Family Health Center

Erzurum, 25080, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Irritable Bowel Syndrome

Interventions

FODMAP DietDiet, Gluten-Free

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Elimination DietsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaDiet TherapyNutrition TherapyTherapeutics

Study Officials

  • Ertuğrul Çoruh, MD

    Yıldızkent Family Health Center, Palandöken District Health Directorate, Erzurum, Turkey

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were assigned to one of two parallel dietary intervention groups
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Family Physician

Study Record Dates

First Submitted

August 25, 2026

First Posted

September 2, 2026

Study Start

December 24, 2025

Primary Completion

July 20, 2026

Study Completion

July 25, 2026

Last Updated

September 2, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations